Fifth Third Bancorp’s CareDx CDNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$15.6K Hold
549
﹤0.01% 3617
2026
Q1
$9.53K Buy
+549
New +$10.4K ﹤0.01% 3713
2023
Q3
Sell
-1,690
Closed -$14.4K 2593
2023
Q2
$14.4K Buy
+1,690
New +$14.1K ﹤0.01% 1857
2022
Q4
Sell
-393
Closed -$7K 2664
2022
Q3
$7K Sell
393
-32
-8% -$687 ﹤0.01% 2062
2022
Q2
$9K Sell
425
-17
-4% -$471 ﹤0.01% 2032
2022
Q1
$16K Buy
442
+6
+1% +$234 ﹤0.01% 1887
2021
Q4
$20K Buy
436
+107
+33% +$5.58K ﹤0.01% 1850
2021
Q3
$21K Buy
329
+236
+254% +$18K ﹤0.01% 1772
2021
Q2
$9K Buy
+93
New +$7.39K ﹤0.01% 2036
2019
Q3
Sell
-106
Closed -$4K 2185
2019
Q2
$4K Buy
+106
New +$3.39K ﹤0.01% 2024

Other funds holding CDNA

Fifth Third Bancorp's CDNA Position: Q2 2026 in Review

Fifth Third Bancorp held its CareDx (CDNA) position steady in Q2 2026 at 549 shares worth $15.6K. The position accounts for ﹤0.01% of the portfolio, ranked #3617.

Fifth Third Bancorp first reported a position in CDNA in Q2 2019 and has held it in 10 quarters since. The position peaked at $21K in Q3 2021. 227 funds tracked by Wall St. Rank hold CDNA as of Q2 2026.

  • Fifth Third Bancorp held 549 shares of CareDx worth $15.6K as of Q2 2026.
  • Fifth Third Bancorp left its CareDx share count unchanged in Q2 2026.
  • CareDx made up ﹤0.01% of Fifth Third Bancorp's portfolio in Q2 2026, its #3617 holding.
  • Fifth Third Bancorp first reported a position in CareDx in Q2 2019 and has held it in 10 quarters since.
  • Fifth Third Bancorp's CareDx position peaked at $21K in Q3 2021.
  • 227 funds tracked by Wall St. Rank held CareDx as of Q2 2026.

Based on Fifth Third Bancorp's 13F filing for Q2 2026, filed 5 Aug 2026.